Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair. | Cancers (Basel) | 2023 | 38136266 | PubTator, text mining | PubMed |
| Integrative Analysis of the Role of TP53 in Human Pan-Cancer. | Curr Issues Mol Biol | 2023 | 38132447 | PubTator, text mining | PubMed |
| Male Breast: A Review of the Literature and Current State of the Art of Diagnostic Imaging Work-Up. | Diagnostics (Basel) | 2023 | 38132204 | PubTator, text mining | PubMed |
| Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. | Cells | 2023 | 38132164 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. | Cell Discov | 2023 | 38114467 | PubTator, text mining | PubMed |
| Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization. | Front Oncol | 2023 | 38111536 | PubTator, text mining | PubMed |
| PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview. | Ther Adv Med Oncol | 2023 | 38107827 | PubTator, text mining | PubMed |
| Microgravity triggers ferroptosis and accelerates senescence in the MG-63 cell model of osteoblastic cells. | NPJ Microgravity | 2023 | 38104197 | PubTator, text mining | PubMed |
| ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes. | Nat Commun | 2023 | 38097570 | PubTator, text mining | PubMed |
| Personalized medicine in a community health system: the NorthShore experience. | Front Genet | 2023 | 38090148 | PubTator, text mining | PubMed |
| Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~. | Genes Environ | 2023 | 38082340 | PubTator, text mining | PubMed |
| Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor. | bioRxiv | 2023 | 38076829 | PubTator, text mining | PubMed |
| Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance. | Front Genet | 2023 | 38075690 | PubTator, text mining | PubMed |
| Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition? | Int J Mol Sci | 2023 | 38069345 | PubTator, text mining | PubMed |
| CellTool: An Open-Source Software Combining Bio-Image Analysis and Mathematical Modeling for the Study of DNA Repair Dynamics. | Int J Mol Sci | 2023 | 38069107 | PubTator, text mining | PubMed |
| Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. | Cancers (Basel) | 2023 | 38067403 | PubTator, text mining | PubMed |
| Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer. | Cancers (Basel) | 2023 | 38067280 | PubTator, text mining | PubMed |
| Cancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Study. | JCO Glob Oncol | 2023 | 38060977 | PubTator, text mining | PubMed |
| Epidemiological and Clinical Characteristics of Young Patients With Breast Cancer in Brazil: A Retrospective Study. | JCO Glob Oncol | 2023 | 38060974 | PubTator, text mining | PubMed |
| Clinical and functional analysis of the germline TP53 p.K164E acetylation site variant. | Cold Spring Harb Mol Case Stud | 2023 | 38050059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=16